[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:retinal-vein-occlusion":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":36,"states":37},"Retinal Vein Occlusion",4,3,[8,15,22,28],{"nct_id":9,"title":10,"phases":11,"status":12,"updated_at":13,"content_modified":14},"NCT04505618","Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease",[],"RECRUITING","2026-08-26T02:16:02.918558Z","2026-05-05T02:43:28.192645Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":20,"content_modified":21},"NCT04008121","Feasibility and Safety of MB-102 in Ocular Angiography as Compared to Fluorescein Sodium",[19],"Early Phase 1","2026-08-26T02:19:00.742020Z","2026-05-05T02:43:27.316203Z",{"nct_id":23,"title":24,"phases":25,"status":12,"updated_at":26,"content_modified":27},"NCT01496625","National Eye Institute Biorepository for Retinal Diseases",[],"2026-08-26T02:16:03.788292Z","2026-05-13T02:55:06.073482Z",{"nct_id":29,"title":30,"phases":31,"status":33,"updated_at":34,"content_modified":35},"NCT07456826","Study Evaluating the Efficacy and Safety of Chloroprocaine HCl Ophthalmic Gel 3% vs Proparacaine Ophthalmic Solution 0.5% Plus Subconjunctival Lidocaine in Patients Undergoing Intravitreal Injections",[32],"Phase 4","ENROLLING_BY_INVITATION","2026-08-26T02:18:05.435729Z","2026-06-16T05:54:07.885745Z",[],[]]